Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1810560 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $1.04Day −2.08%Mkt cap $4M1Y −90.4%Off 52W high −91.1%Vol (1Y) 76.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,743 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.5% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)−0.00% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$9.9M |
| ROE−131.4% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−67.6% |
| 1Y−90.4% |
| 3Y−100.0% |
| 5Y−100.0% |
| Since incept. (ann.)−77.7% |
Total return through 2026-07-28 · series begins 2016-08-25. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)76.4% |
| Ann. volatility (3Y)116.2% |
| Sharpe (1Y)−2.70 |
| Sharpe (3Y)−1.74 |
| Max drawdown (1Y)−91.8% |
| Max drawdown (3Y)−100.0% |
| Beta (3Y vs SPY)−0.36 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 323,241 | $387,889 | 8.27% | new |
| SABBY MANAGEMENT, LLC | 99,432 | $119,318 | 2.54% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 43,195 | $51,833 | 1.11% | new |
| VANGUARD FIDUCIARY TRUST CO | 13,127 | $15,752 | 0.34% | new |
| XTX Topco Ltd | 11,385 | $13,662 | 0.29% | new |
| UBS Group AG | 4,115 | $4,938 | 0.11% | new |
| Tower Research Capital LLC (TRC) | 4,074 | $4,889 | 0.10% | new |
| ROYAL BANK OF CANADA | 747 | $1,000 | 0.02% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$2.71 | — | — | — |
| 2025-09-30 | 2025-11-06 | — | — | — | — |
| 2025-06-30 | 2025-08-08 | — | — | — | — |
| 2025-03-31 | 2025-05-08 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
